Journal of Cancer Prevention

eISSN 2288-3657
pISSN 2288-3649
Fig. 3.

Download original image

Fig. 3. The ORR and DCR of the 43 patients with metastatic CRC who received apatinib plus PD-1 blockades treatment.
ORR, objective response rate; DCR, disease control rate; CRC, colorectal cancer; PD-1, programmed cell death protein 1.
J Cancer Prev 2023;28:106~114 https://doi.org/10.15430/JCP.2023.28.3.106
© J Cancer Prev
© Korean Society of Cancer Prevention. / Powered by INFOrang Co., Ltd